IP Library Granted Patent US 7,795,276
Granted Patent B2
US 7,795,276 · App. 12/022,557 · Granted Sep 14, 2010

Imiadazo[4,5-c] pyridine compound and method of antiviral treatment

Assignees: Gilead Sciences, Inc.; K.U. Leuven Research & Development; Gerhard Puerstinger
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,795,276
App. No.
12/022,557
Granted
Sep 14, 2010
Kind
B2
Abstract

The compound 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2 -(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, together with the salts and solvates thereof. Also provided are compositions comprising this compound and pharmaceutically acceptable carriers, as well as the use of such compositions in the treatment or prophylaxis of viral infections.

Claims (4)

1. 5((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)2-(2-fluorophenyl)-5H-imidazo [4,5-c]pyridine, or a salt thereof.

2. A composition comprising the compound of claim 1 and at least one pharmaceutically acceptable carrier.

3. A method for treatment of an HCV infection comprising administering to a subject from 0.001 mg to 60 mg of a compound of claim 1 .

4. The compound of claim 1 as the free base.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2015
From: GILEAD SCIENCES, INC.
To: K.U. LEUVEN RESEARCH & DEVELOPMENT
Reel/Frame 036495/0004 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2008
From: BONDY, STEVEN S.; OARE, DAVID A.; TSE, WINSTON C.
To: GILEAD SCIENCES, INC.; K.U. LEUVEN RESEARCH & DEVELOPMENT; PUERSTINGER, GERHARD
Reel/Frame 020820/0894 →
Continuity (3)
Continuation 1131605000 · Dec 21, 2005
Provisional Application 6063821500 · Dec 21, 2004
Related Publication 20080188516A1 · Aug 7, 2008